Estrella Immunopharma, Inc.
ESLA
Last
$0.39
Day
-6.5%
1y
-66.1%
5y
-88.0%
52w
-86.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
0.50
EMA 50
0.61
EMA 200
0.97
20d high
-42.8%
5y high
-92.6%
5y range
1th
Positions held
Your positionsESLA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-6
Hold
avoid
Signal
Sell
Target
$0.50
Stop
$0.35
Stop distance
10.3%
Target vs last
+28.1%
Fundamentals
| Market cap | $16.62M | Enterprise value | $18.01M | Trailing P/E | — | Forward P/E | -1.19 |
| PEG | — | Price / book | -2.21 | Beta | 0.93 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | -2.5% | Debt / equity | — |
| Current ratio | 0.20 | Free cash flow | -$6.79M | Analyst recommendation | none | Mean target | $12.00 |
| 52w high | $3.15 | 52w low | $0.31 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$2.3M | -$2.3M | -$0.6M | -$4.8M | -$5.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$2.1M | -$2.3M | -$0.6M | -$4.8M | -$5.5M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$13.1M | -$7.3M | -$11.1M | -$1.7M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$13.1M | -$7.3M | -$11.1M | -$1.7M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsESLA · daily-13.9% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin